Boston Globe

News & Analysis

boston globe and millennium pharmaceuticals inc. - All News and Analysis

• Cambridge, Mass.-Based Pharmaceutical Firm Expects Big Sales for Cancer Drug.

  - 2004-01-13

  By Ross Kerber, The Boston Globe Knight Ridder/Tribune Business News Jan. 13--Millennium Pharmaceuticals Inc. yesterday said it expects to sell up to $160 million worth of its Velcade cancer drug this year, nearly three times its 2003 sales, and said layoffs and...

  Tags: Boston Globe, Millennium Pharmaceuticals Inc., SALES, VELCADE

• Cambridge, Mass., Drug Firm Sees Shares Drop More Than 23 Percent.

  - 2002-10-17

  By Naomi Aoki, The Boston Globe Knight Ridder/Tribune Business News Oct. 17--Shares of Millennium Pharmaceuticals Inc. fell more than 23 percent yesterday, the first day of trading after the Cambridge company reported wider-than-expected third-quarter losses and lowered its 2002 forecast. ...

  Tags: analyst, Boston Globe, Cambridge, FINANCE, Investment, Millennium Pharmaceuticals Inc.

• The Boston Globe Biotechnology Briefs Column.

  - 2002-10-09

  By Naomi Aoki, The Boston Globe Knight Ridder/Tribune Business News Oct. 9--MILLENNIUM, BIOGEN SCORE IN RANKING: Two Cambridge companies, Millennium Pharmaceuticals Inc. and Biogen Inc., were ranked among the top 20 employers in the biotechnology and pharmaceutical industries in a new survey,...

  Tags: Biogen Idec Inc., Biotechnology, Boston Globe, Millennium Pharmaceuticals Inc., Strategy

• Study Shows Massachusetts Firm's Cancer-Fighting Drug Halts Progression.

  - 2002-05-21

  By Naomi Aoki, The Boston Globe Knight Ridder/Tribune Business News May 21--Millennium Pharmaceuticals's most advanced cancer-fighting drug, MLN341, appears to stop or reverse the progression of an often deadly blood-borne form of the disease in most patients, according to preliminary study results presented yesterday...

  Tags: analyst, Boston Globe, Millennium Pharmaceuticals Inc., patient

• Cambridge, Mass., Genomics Research Firm to Close.

  - 2002-04-17

  By Naomi Aoki, The Boston Globe Knight Ridder/Tribune Business News Apr. 17--Cereon Genomics, a wholly owned subsidiary of Monsanto Inc. and a product of its five-year collaboration with Cambridge-based Millennium Pharmaceuticals Inc., will be shut down this summer. The 140 employees...

  Tags: Biotechnology, Boston Globe, Cambridge, Collaboration, FINANCE, Groupware, Manufacturing, Millennium Pharmaceuticals Inc., SOFTWARE, spokesman

• Waltham, Mass., Venture-Capital Firm Recruits Pharmaceutical Executive.

  - 2002-04-04

  By Beth Healy, The Boston Globe Knight Ridder/Tribune Business News Apr. 4--Polaris Venture Partners has recruited Millennium Pharmaceuticals executive Alan Crane to be a venture partner at the Waltham firm. Crane has been vice president of corporate development at Millennium, a...

  Tags: Boston Globe, CAREER, HEALTHCARE, Millennium Pharmaceuticals Inc.

• The Boston Globe Boston Capital Column.

  - 2001-12-16

  By Steven Syre and Charles Stein, The Boston Globe Knight Ridder/Tribune Business News Dec. 16--DEALS BRING BIOTECH TO A NEW PHASE: The biotechnology industry, in the dumps for most of the year, has suddenly developed a case of merger fever. ...

  Tags: Biotechnology, Boston Globe, Millennium Pharmaceuticals Inc.

• Early Study Results Promising for Cambridge, Mass., Firm's Cancer Drug.

  - 2001-12-11

  By Naomi Aoki, The Boston Globe Knight Ridder/Tribune Business News Dec. 11--Millennium Pharmaceuticals' most important cancer-fighting drug, LDP-341, appears effective in fighting an often deadly blood-borne form of the disease in patients who failed to respond to other treatments, according to preliminary study results...

  Tags: Boston Globe, cell, Millennium Pharmaceuticals Inc., patient

• FDA Approves Millennium Pharmaceuticals' Leukemia Drug.

  - 2001-05-09

  The Boston Globe Knight Ridder/Tribune Business News May 9--Millennium Pharmaceuticals Inc. this week joined the elite ranks of such Cambridge neighbors as Genzyme Corp., Biogen Inc., Genetics Institute and Vertex Pharmaceuticals Inc. in getting its first drug approved by the U.S. Food...

  Tags: Biopure Corp., Boston Globe, Cambridge, FDA, Genzyme Corp., Millennium Pharmaceuticals Inc., patient

• Cambridge, Mass.-Based Biotech Companies Will Create Cancer-Seeking Drugs.

  - 2001-03-06

  By Naomi Aoki, The Boston Globe Knight Ridder/Tribune Business News Mar. 6--Millennium Pharmaceuticals Inc. and ImmunoGen Inc. yesterday said Millennium will use ImmunoGen's seek-and-destroy technology to create cancer drugs that obliterate tumors without harming healthy cells. The technology, Tumor-Activated Prodrug, or...

  Tags: Biotechnology, Boston Globe, cell, ImmunoGen Inc., Millennium Pharmaceuticals Inc.